Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05309187 |
Title | Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Immune-Onc Therapeutics Inc |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
USC-Norris Comprehensive Cancer Center (119) | Los Angeles | California | 90033 | United States | Details | |
University of Florida (125) | Gainesville | Florida | 32610-0278 | United States | Details | |
Northwestern University - Feinberg School of Medicine (133) | Chicago | Illinois | 60611 | United States | Details | |
Indiana University (123) | Indianapolis | Indiana | 46202 | United States | Details | |
Tisch Mount Sinai (124) | New York | New York | 10029 | United States | Details | |
Carolina BioOncology (102) | Huntsville | North Carolina | 28078 | United States | Details | |
Sarah Cannon Research Institute/Tennessee Oncology (122) | Nashville | Tennessee | 37203 | United States | Details | |
Mary Crowley Cancer Research (108) | Dallas | Texas | 75251 | United States | Details | |
MD Anderson Cancer Center (101) | Houston | Texas | 77030 | United States | Details | |
NEXT Oncology Virginia (121) | Fairfax | Virginia | 22031 | United States | Details |